TOKYO - AstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daiichi’s cancer drug trastuzumab deruxtecan that could see the British drugmaker pay as much as $6.9 billion to its Japanese partner.
Under the deal, AstraZeneca will make an upfront payment of $1.35 billion to Daiichi. They will share development and commercialization costs for the drug worldwide, with Daiichi retaining exclusive rights in Japan. The deal is also a big bet on Japanese research by AstraZeneca Chief Executive Pascal Soriot, who is seeing results in his efforts to replenish the British drugmaker’s pipeline as its cancer drug sales grow.
The drug also has the potential to treat lung and colorectal cancers. AstraZeneca plans to use some of the proceeds of a $3.5 billion share issue to fund the deal. Daiichi is expected to book sales for the cancer drug in the United States, certain countries in Europe and some other markets where it has affiliates.
Cancer patients are pawns in the drug and oncology industries. I firmly believe that research that leans toward cure rather than drug maintenance is financially stifled to prevent it from moving forward.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca could pay Daiichi Sankyo up to $6.9 billion in cancer drug dealAstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daii...
Source: Reuters - 🏆 2. / 97 Read more »
AstraZeneca inks $6.9 billion cancer drug pact with Japanese pharma firm Daiichi SankyoAstraZeneca and Japan's Daiichi Sankyo signed a potential multibillion-dollar deal to develop and sell Daiichi's cancer drug trastuzumab deruxtecan. Bpjs
Source: BusinessInsider - 🏆 729. / 51 Read more »
AstraZeneca Strikes $6.9 Billion Cancer Deal With Japanese DrugmakerAstraZeneca has agreed to pay Japan’s Daiichi Sankyo up to $6.9 billion for part of the rights to a promising next-generation cancer treatment, as the Anglo-Swedish pharmaceutical group continues to strengthen its oncology drug pipeline. Dear ....Please share with ADULTS that 'Smoking,Alcoholism,Drug,PORN,Premarital Sex and Extramarital affairs' are very bad habits and explain the CONSEQUENCES with Logical points......This will also help for your CANCER prevention. I have to say even by the standards of the onco space, this looks like a pricey deal. It sure puts to bed any idea that CNese lo-balling me-too onco mols are going to break the existing pricing model in developed markets any time soon!!
Source: WSJ - 🏆 98. / 63 Read more »
How this cancer drug has shown promise for the treatment of dementiaNot all drug development needs to start from scratch. Sometimes researchers discover that a drug developed for one disease can be used for another. _CancerCoaches
Source: Newsweek - 🏆 468. / 52 Read more »
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialJury says Bayer, which bought Monsanto last year, must pay $81 million to a man who claimed the company's Roundup weed killer caused his non-Hodgkin's lymphoma Scientifically proven NOT to cause cancer. Great! But NOT GOOD ENOUGH!! Round-Up should be BANNED and REMOVED FROM THE SHELVES IMMEDIATELY!! Boggles any scientific mind
Source: Reuters - 🏆 2. / 97 Read more »
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. The jury in San Francisco federal court said the company was liable for ANOTHER BAYER PRODUCT TO BE BOYCOTTED
Source: YahooNews - 🏆 380. / 59 Read more »
Jury says Bayer must pay $81 million to man who alleged Roundup caused his cancerA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. Bayer Causing a toxic / poisonous environment with Round Up and by advertising on Fox News. This company is killing us all over. What it sounds like is someone is practicing counter sue
Source: CNBC - 🏆 12. / 72 Read more »